These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1089 related articles for article (PubMed ID: 407343)

  • 1. Hydroxyanisole-induced regression of the Harding-Passey melanoma in mice.
    Dewey DL; Butcher FW; Galpine AR
    J Pathol; 1977 Jul; 122(3):117-27. PubMed ID: 407343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-selective action of 4-hydroxyanisole on melanoma cells in vivo.
    Schwabe K; Fichtner I; Tschiersch B
    Pigment Cell Res; 1990; 3(1):8-10. PubMed ID: 2116000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of growth inhibition of melanoma by 4-hydroxyanisole.
    Kulkarni GA; Nathanson L
    Pigment Cell Res; 1989; 2(1):40-3. PubMed ID: 2497444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatments with alpha-difluoromethylornithine and hyperthermia on the growth and polyamine metabolism of Harding-Passey murine melanoma.
    Lopez Ballester JA; Peñafiel R; Cremades A; Valcarcel MM; Solano F; Lozano JA
    Anticancer Res; 1991; 11(2):691-6. PubMed ID: 1905904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural study of the persistence of colchicine-induced cytological changes in Harding-Passey melanoma.
    Loader KR; Nathaniel EJ
    Cancer Res; 1978 Jan; 38(1):168-76. PubMed ID: 563286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidants BHT and BHA and their effect on B-16 murine melanoma (author's transl)].
    Kanclerz A; Zbytniewski Z
    Cesk Dermatol; 1981 Apr; 56(2):85-8. PubMed ID: 7237599
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of scheduling of combinations of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on the Harding-Passey and Cloudman S91 mouse melanomas.
    Hill HZ; Hill GJ
    Cancer Res; 1982 Mar; 42(3):838-42. PubMed ID: 7059982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of histidine at the active site of Harding-Passey mouse melanoma tyrosinase.
    Martínez JH; Solano F; García-Borrón JC; Iborra JL; Lozano JA
    Biochem Int; 1985 Nov; 11(5):729-38. PubMed ID: 3937527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of tyrosinase activity and phospholipid composition in Harding-Passey melanoma microsomal fraction].
    Shtol'ko VN; Bogdanov GN; Vasil'eva LS; Burlakova EB
    Biokhimiia; 1978 Jan; 43(1):121-6. PubMed ID: 414789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapeutic effect of naphthidon-3H in combined action on Harding-Passey melanoma].
    Bobrova VN; Gavrilenko IS; Ivanov II; Shestakov AD
    Vopr Onkol; 1975; 21(1):52-7. PubMed ID: 1119121
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines.
    Dutkiewicz R; Albert DM; Levin LA
    Exp Eye Res; 2000 May; 70(5):563-9. PubMed ID: 10870514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of endogenous proteases on the distribution of tyrosinase isozymes in Harding-Passey mouse melanoma.
    Martinez JH; Solano F; Lozano JA
    Cell Biochem Funct; 1989 Jan; 7(1):21-6. PubMed ID: 2502324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of a new benzodiazepine derivative on experimental malignant melanomas].
    Werner W; Wohlrabe K; Fichtner I; Wohlrab W
    Arch Geschwulstforsch; 1987; 57(1):17-23. PubMed ID: 3566461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of retinoids on growth and melanin content of Harding-Passey-melanoma cells in vitro and B16 transplantable melanoma in vivo.
    Drewa G; Schachtschabel DO
    Arch Geschwulstforsch; 1985; 55(2):93-8. PubMed ID: 4004512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunologic reactivity of mice with transplantable Harding-Passey melanoma].
    Kovalev IE; Grigor'ian-Kovaleva VL; Rubtsova ED; Burkin AA; Shaĭdrov VV
    Vopr Onkol; 1971; 17(4):55-8. PubMed ID: 4935523
    [No Abstract]   [Full Text] [Related]  

  • 17. Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cells.
    Lejeune FJ
    Yale J Biol Med; 1973 Dec; 46(5):368-83. PubMed ID: 4205114
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.
    Vile RG; Hart IR
    Cancer Res; 1993 Sep; 53(17):3860-4. PubMed ID: 8395331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytologic features of Harding-Passey melanoma following different regimes of colchicine treatment.
    Loader KR; Nathaniel EJ
    Am J Pathol; 1977 Nov; 89(2):297-312. PubMed ID: 562621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron microscopic observations on cells of Harding-Passey melanoma following colchicine administration.
    Nathaniel EJ; Friedman NB; Rychuk H
    Cancer Res; 1968 Jun; 28(6):1031-40. PubMed ID: 5658438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 55.